Development and Characterization of Gemcitabine-Resistant Pancreatic Tumor Cells

被引：0
|
作者：
Ami N. Shah
Justin M. Summy
Jing Zhang
Serk In Park
Nila U. Parikh
Gary E. Gallick
机构：
[1] University of Texas M.D. Anderson Cancer Center,Department of Surgical Oncology
[2] University of Texas M.D. Anderson Cancer Center,Department of Cancer Biology
来源：
Annals of Surgical Oncology | 2007年 / 14卷
关键词：
Pancreatic cancer; EMT; Gemcitabine chemoresistance; c-Met; Cancer stem cells;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3629 / 3637
页数：8
相关论文
共 50 条
  • [1] Development and characterization of gemcitabine-resistant pancreatic tumor cells
    Shah, Ami N.
    Summy, Justin M.
    Zhang, Jing
    Park, Serk In
    Parikh, Nila U.
    Gallick, Gary E.
    ANNALS OF SURGICAL ONCOLOGY, 2007, 14 (12) : 3629 - 3637
  • [2] Gemcitabine-resistant pancreatic ductal adenocarcinoma cells promote immunosuppressive tumor microenvironment
    Kajiwara, Yoshinori
    Tazawa, Hiroshi
    Nishiyama, Takeyoshi
    Shoji, Ryohei
    Fushimi, Takuro
    Kikuchi, Satoru
    Kuroda, Shinji
    Noma, Kazuhiro
    Yoshida, Ryuichi
    Nishizaki, Masahiko
    Kagawa, Shunsuke
    Fujiwara, Toshiyoshi
    CANCER SCIENCE, 2021, 112 : 560 - 560
  • [3] Anti-tumor effect of avadomide in gemcitabine-resistant pancreatic ductal adenocarcinoma
    Nishi, Hidemi
    Gotoh, Kunihito
    Tomimaru, Yoshito
    Kobayashi, Shogo
    Sasaki, Kazuki
    Iwagami, Yoshifumi
    Yamada, Daisaku
    Akita, Hirofumi
    Asaoka, Tadafumi
    Noda, Takehiro
    Takahashi, Hidenori
    Tanemura, Masahiro
    Doki, Yuichiro
    Eguchi, Hidetoshi
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2023, 92 (04) : 303 - 314
  • [4] Anti-tumor effect of avadomide in gemcitabine-resistant pancreatic ductal adenocarcinoma
    Hidemi Nishi
    Kunihito Gotoh
    Yoshito Tomimaru
    Shogo Kobayashi
    Kazuki Sasaki
    Yoshifumi Iwagami
    Daisaku Yamada
    Hirofumi Akita
    Tadafumi Asaoka
    Takehiro Noda
    Hidenori Takahashi
    Masahiro Tanemura
    Yuichiro Doki
    Hidetoshi Eguchi
    Cancer Chemotherapy and Pharmacology, 2023, 92 : 303 - 314
  • [5] IFN-γ induces apoptosis in gemcitabine-resistant pancreatic cancer cells
    Kong, Xiangxin
    Cheng, Denglong
    Xu, Xu
    Zhang, Yuan
    Li, Xin
    Pan, Wanlong
    MOLECULAR MEDICINE REPORTS, 2024, 29 (05)
  • [6] Combination effect of metformin with gemcitabine for gemcitabine-resistant pancreatic adenocarcinoma
    Suzuki, Keiichi
    Takeuchi, Osamu
    Osaku, Masayoshi
    Yamada, Yoshinori
    CANCER RESEARCH, 2014, 74 (19)
  • [7] The mechanism of anti-tumor effect of metformin for gemcitabine-resistant pancreatic adenocarcinoma
    Suzuki, Keiichi
    Takeuchi, Osamu
    Ishii, Yoshiyuki
    Osaku, Masayoshi
    CANCER RESEARCH, 2015, 75
  • [8] The efficiency of anti-tumor effect of mefformin for gemcitabine-resistant pancreatic adenocarcinoma
    Suzuki, Keiichi
    Takeuchi, Osamu
    Ishii, Yoshiyuki
    Osaku, Masayoshi
    CANCER RESEARCH, 2016, 76
  • [9] An exploratory study on the mechanism of pralatrexate killing gemcitabine-resistant pancreatic cancer cells
    Weng, W.
    Hong, J.
    Jiang, D.
    Chen, B.
    Zheng, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S431 - S431
  • [10] Identification of a Novel Subpopulation of Tumor-Initiating Cells from Gemcitabine-Resistant Pancreatic Ductal Adenocarcinoma Patients
    Shimizu, Kazuya
    Chiba, Sachie
    Hori, Yuichi
    PLOS ONE, 2013, 8 (11):
12345